The global azacitidine market is anticipated to grow at a CAGR of 4.95 % during the forecast period. The primary factor contributing to the growth of the market is the increasing incidence of chronic diseases such as cancer, acute leukaemia, and cerebrovascular diseases. According to the WHO, in 2019, around 6.6 million deaths were caused due to cerebrovascular diseases globally. Due to this increasing burden of the disease, it is expected to fuel the growth of the market during the forecast period.

Azacitidine is a chemotherapy drug that is used for the treatment of blood and bone marrow diseases. It is a condition where bone marrow is not able to produce new cells. The increasing prevalence of disorders like breast cancer and melanoma across the globe will fuel the demand for the drug during the forecast period. More shifts towards chemotherapy rather than using blood transfusion for the treatment is also one of the factors that will propel the growth of the market. 

Some of the key global players in the global azacitidine market include Eisai Co. Ltd., Pfizer, Inc., Sanofi, Teva Pharmaceuticals Industries Ltd., Novartis AG, Intas Pharmaceuticals Ltd., and many others. For instance, in September 2021, Intas Pharmaceuticals Ltd. launched India’s first oral therapy drug called Azdadine-O. The drug will be used for the treatment of myeloid leukaemia and can improve the patients’ chances of survival by 10 months while avoiding the need for cancer therapy. 

Market Coverage

• The market number available for – 2020-2027
• Base year- 2020
• Forecast period- 2021-2027
• Segment Covered- 

o By Application

o By Route of Administration

o By End-User 

• Competitive Landscape - Eisai Co. Ltd., Pfizer, Inc., Sanofi, Teva Pharmaceuticals Industries Ltd., Novartis AG, Intas Pharmaceuticals Ltd.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominates the market in base year?
• Which segment and region will project fastest growth in the market?
• How COVID-19 impacted the market?

o Recovery Timeline

o Deviation from pre-COVID forecast

o Most affected region and segment

• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Azacitidine Market by Segments

• By Application 

o Refractory anaemia

o Chronic myelomonocytic leukaemia

• By Route of Administration

o Oral

o Injectable

o Others

• By End-User 

o Hospitals

o Home care

o Speciality clinics

o Others

Global Azacitidine Market by Regions